Jorge Marcos
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Lilly USA, LLC at 56.5% of the total. Reporting peaked in 2022 at $6,304 and has fallen 95.2% since, to $304 in 2025.
Across 156 payments — averaging $66.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$6K
- UCB, Inc.$1K
- Neurocrine Biosciences, Inc.$531
- Adamas Pharmaceuticals, Inc.$470
- Teva Pharmaceuticals USA, Inc.$402
- SK Life Science, Inc.$252
- plus $2K from 22 others
What the payments were for
- Consulting fees$4,00039%
- Travel & lodging$1,11411%
- Food & beverage$5,22551%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 25 | $5,840 |
| UCB, Inc. | 37 | $1,093 |
| Neurocrine Biosciences, Inc. | 13 | $531 |
| Adamas Pharmaceuticals, Inc. | 19 | $470 |
| Teva Pharmaceuticals USA, Inc. | 11 | $402 |
| SK Life Science, Inc. | 8 | $252 |
| Sunovion Pharmaceuticals Inc. | 4 | $176 |
| AstraZeneca(2 entities) | 3 | $173 |
| Amneal Pharmaceuticals LLC | 2 | $143 |
| Kyowa Kirin, Inc. | 7 | $143 |
| Insightec,inc | 1 | $139 |
| Sanofi | 2 | $131 |
| Eisai Inc. | 2 | $125 |
| Acadia Pharmaceuticals Inc | 1 | $123 |
| Amgen | 1 | $115 |
| AbbVie(2 entities) | 5 | $98 |
| TG Therapeutics, Inc. | 1 | $65 |
| Lundbeck LLC | 1 | $65 |
| Biogen | 3 | $49 |
| GE HealthCare | 2 | $39 |
| Neurelis, Inc. | 1 | $25 |
| CSL Behring | 1 | $23 |
| Aprecia Pharmaceuticals, LLC | 1 | $22 |
| Avanir Pharmaceuticals, Inc. | 1 | $22 |
| Avion Pharmaceuticals | 1 | $21 |
| Cala Health, Inc. | 1 | $21 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
| Acorda Therapeutics, Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,339 in reported general payments places this provider in the 75th percentile of 1,434 neurology providers in Florida.
Other neurology in Miami
- Diego Torres-RussottoMiami$652K
- Bruno GalloMiami$313K
- Brad HerskowitzMiami$273K
- Flavia NelsonMiami$264K
- Corneliu LucaMiami$257K
- Kottil RammohanMiami$176K
- Stuart IsaacsonBoca Raton$3.9M
- Selim BenbadisTampa$2.1M
- Derrick RobertsonTampa$1.8M
- Robert HauserTampa$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.